Skip to content

Michael V. Genuardi, MD

NPI 1275897746ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Philadelphia, PA

Internal Medicine, Advanced Heart Failure and Transplant Cardiology (MD) in Philadelphia, Pennsylvania, trained at Tufts University School of Medicine (class of 2012). Their prescriptions cost Medicare Part D more than their services did: $799,612 for 1,864 claims, against $88,456 paid for services in 2024. Alnylam Pharmaceuticals Inc. was the largest of 3 companies reporting payments in 2025, $270.07 in all, mostly food and beverage.

Overview

NPI1275897746
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 29, 2012
Last updated in NPPESOct 11, 2021
Certified by providerOct 11, 2021

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (PA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients797
Services billed1,924 across 24 procedure codes
Paid by Medicare$88,456

Part D prescriptions in 2024

Prescriptions (claims)1,864 · 4,235 30-day fills
Patients308
Total drug cost$799,612
Generic share71% of claims

Medicare sources and data years

Education and affiliations

Medical schoolTufts University School of Medicine
Graduation year2012
Medicare specialtyAdvanced Heart Failure And Transplant Cardiology
Secondary specialtiesCardiovascular Disease (Cardiology)
TelehealthOffers telehealth

Medical group

Hospital affiliations

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$270.07 · 4 payments from 3 companies
  • 2024$1,704 · 14 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Alnylam Pharmaceuticals Inc.$125.471
Cvrx, Inc.$118.292
Abbott Laboratories$26.311

What the 2025 payments were for

  • Food and Beverage$270.07 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Philadelphia

All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Pennsylvania →